![Effect of combined treatment with bisphosphonate and vitamin D on atherosclerosis in patients with systemic lupus erythematosus: a propensity score-based analysis | Arthritis Research & Therapy | Full Text Effect of combined treatment with bisphosphonate and vitamin D on atherosclerosis in patients with systemic lupus erythematosus: a propensity score-based analysis | Arthritis Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13075-018-1589-9/MediaObjects/13075_2018_1589_Fig1_HTML.gif)
Effect of combined treatment with bisphosphonate and vitamin D on atherosclerosis in patients with systemic lupus erythematosus: a propensity score-based analysis | Arthritis Research & Therapy | Full Text
![Bisphosphonates for Bone Disease in HIV -- and Advice on Antiretrovirals, Calcium, Vitamin D and Glitazones Bisphosphonates for Bone Disease in HIV -- and Advice on Antiretrovirals, Calcium, Vitamin D and Glitazones](https://images.ctfassets.net/pdtztwrkphaf/tbart_tb_76417_body_1_image/8a563c8e59df1849624ac72a783c034a/bisphosphonates.jpg?w=388&fm=jpg&fit=thumb&q=65&fl=progressive)
Bisphosphonates for Bone Disease in HIV -- and Advice on Antiretrovirals, Calcium, Vitamin D and Glitazones
![Effect of vitamin D on bone mineral density of elderly patients with osteoporosis responding poorly to bisphosphonates | BMC Musculoskeletal Disorders | Full Text Effect of vitamin D on bone mineral density of elderly patients with osteoporosis responding poorly to bisphosphonates | BMC Musculoskeletal Disorders | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2474-3-6/MediaObjects/12891_2001_Article_17_Fig1_HTML.jpg)
Effect of vitamin D on bone mineral density of elderly patients with osteoporosis responding poorly to bisphosphonates | BMC Musculoskeletal Disorders | Full Text
2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid‐Induced Osteoporosi
![Nutrients | Free Full-Text | Medication-Related Osteonecrosis of the Jaw (MRONJ): Are Antiresorptive Drugs the Main Culprits or Only Accomplices? The Triggering Role of Vitamin D Deficiency Nutrients | Free Full-Text | Medication-Related Osteonecrosis of the Jaw (MRONJ): Are Antiresorptive Drugs the Main Culprits or Only Accomplices? The Triggering Role of Vitamin D Deficiency](https://pub.mdpi-res.com/nutrients/nutrients-13-00561/article_deploy/html/images/nutrients-13-00561-ag.png?1612931857)
Nutrients | Free Full-Text | Medication-Related Osteonecrosis of the Jaw (MRONJ): Are Antiresorptive Drugs the Main Culprits or Only Accomplices? The Triggering Role of Vitamin D Deficiency
Happy Friday! Here is another DYR for the books! . . . . . . . . . The answer is Vitamin D3! Fosamax Plus D contains Alendronate sodium, bisphosphonate, and cholecalciferol (
![The role of calcium and vitamin D in the prevention and treatment of osteoporosis - Revista de Osteoporosis y Metabolismo Mineral · Publicación Oficial SEIOMM The role of calcium and vitamin D in the prevention and treatment of osteoporosis - Revista de Osteoporosis y Metabolismo Mineral · Publicación Oficial SEIOMM](http://revistadeosteoporosisymetabolismomineral.com/imagenes/articulos/9201911010130017_eng-t1.gif)
The role of calcium and vitamin D in the prevention and treatment of osteoporosis - Revista de Osteoporosis y Metabolismo Mineral · Publicación Oficial SEIOMM
![Prevention of aromatase inhibitor-induced bone loss with alendronate in postmenopausal women: The BATMAN Trial - ScienceDirect Prevention of aromatase inhibitor-induced bone loss with alendronate in postmenopausal women: The BATMAN Trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S221213741300047X-gr1.jpg)
Prevention of aromatase inhibitor-induced bone loss with alendronate in postmenopausal women: The BATMAN Trial - ScienceDirect
![Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment - Annals of Oncology Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment - Annals of Oncology](https://www.annalsofoncology.org/cms/asset/d035a26e-eb86-4951-8172-3d437e512fbc/gr1.jpg)
Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment - Annals of Oncology
![The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis | BMC Musculoskeletal Disorders | Full Text The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis | BMC Musculoskeletal Disorders | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2474-8-3/MediaObjects/12891_2006_Article_280_Fig2_HTML.jpg)
The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis | BMC Musculoskeletal Disorders | Full Text
![The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis | BMC Musculoskeletal Disorders | Full Text The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis | BMC Musculoskeletal Disorders | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2474-8-3/MediaObjects/12891_2006_Article_280_Fig7_HTML.jpg)
The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis | BMC Musculoskeletal Disorders | Full Text
![Frontiers | Advances in Our Understanding of the Mechanism of Action of Drugs (including Traditional Chinese Medicines) for the Intervention and Treatment of Osteoporosis Frontiers | Advances in Our Understanding of the Mechanism of Action of Drugs (including Traditional Chinese Medicines) for the Intervention and Treatment of Osteoporosis](https://www.frontiersin.org/files/Articles/938447/fphar-13-938447-HTML/image_m/fphar-13-938447-g001.jpg)